Opioid Withdrawal
📧 Sign up to get email alerts when something new happens for Opioid Withdrawal.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Results: An Innovative Intervention for OUD Treatment [Phase 2, Phase 3]
Phase 2 and Phase 3 clinical trial results for a new intervention in opioid use disorder treatment have been completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: An Innovative Intervention for OUD Treatment [Phase 2, Phase 3]
Phase 2/3 clinical trial update for an innovative intervention targeting opioid-related disorders, completed with results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Sublingual Dexmedetomidine for Treating Opioid Withdrawal [Phase 1, Phase 2]
Clinical trial update shows Phase 1/2 evaluation of sublingual dexmedetomidine for opioid withdrawal. The study is currently active but not …
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD [Phase 2, Phase 3]
A Phase 2/3 trial evaluating pramipexole for restless legs symptoms to improve outcomes during protracted opioid withdrawal in opioid use di…
-
CLINICAL_TRIALS trial_result · 2025-07-04Clinical Trial Update: Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder [NA]
This clinical trial update indicates that a study of transcutaneous auricular neurostimulation for relapse prevention in opioid use disorder…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-21Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled pilot study evaluating LUCEMYRA (lofexidine) during opioid taper in withdrawal was te…
-
CLINICAL_TRIALS trial_result · 2024-05-20Clinical Trial Update: Combining Pregabalin (LYRICA®) With Lofexidine (LUCEMYRATM) to Treat OPIOID Withdrawal [Phase 2]
Phase 2 trial evaluating the combination of pregabalin (Lyrica) and lofexidine (Lucemyra) for opioid withdrawal; results were posted after c…
-
CLINICAL_TRIALS trial_result · 2023-10-26Clinical Trial Update: Dexmedetomidine in the Treatment of Symptoms Of Acute Opioid Withdrawal [Phase 1, Phase 2]
Clinical trial update for dexmedetomidine in treating symptoms of acute opioid withdrawal (Phase 1/2) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-29Clinical Trial Update: Oral Cannabidiol for Opioid Withdrawal [Phase 1, Phase 2]
A Phase 1/2 trial evaluating oral cannabidiol for opioid withdrawal and craving has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Medical Management of Sleep Disturbance During Opioid Tapering [Phase 2]
Phase 2 trial evaluating medical management of sleep disturbance during opioid tapering in opioid dependence/withdrawal.
-
CLINICAL_TRIALS trial_result · 2022-02-23Clinical Trial Update: Lofexidine for Adults Undergoing Lumbar Spine Surgery [Phase 4]
Phase 4 clinical trial update on lofexidine for adults undergoing lumbar spine surgery, focusing on opioid withdrawal management; study comp…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: High Dosage Buprenorphine as a Drug Strategy Withdrawal Assistance of Analgesics Opioid [Phase 2]
A Phase 2 clinical trial investigating high dosage buprenorphine for withdrawal assistance in analgesic opioid use.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Open-Label, Safety Study of Lofexidine [Phase 3]
Open-label safety study of lofexidine in opioid withdrawal completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2020-04-07Clinical Trial Update: Pregabalin for Opiate Withdrawal Syndrome [Phase 4]
Phase 4 clinical trial assessing pregabalin for opioid withdrawal; study completed.
-
CLINICAL_TRIALS trial_result · 2019-08-07Clinical Trial Update: Oxytocin Treatment of Opioid Dependence [Phase 1, Phase 2]
Phase 1/2 clinical trial update on oxytocin treatment for opioid dependence and withdrawal.
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Buprenorphine in the Emergency Department [Phase 4]
A Phase 4 clinical trial evaluating buprenorphine in the emergency department for opioid withdrawal and opioid-use disorder has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Tramadol to Reduce Opioid Withdrawal Symptoms [Phase 2]
Phase 2 clinical trial evaluating tramadol for reducing opioid withdrawal symptoms in people with opioid use disorder; the study has complet…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Effects of Dynorphin 1-13 on Heroin Addiction - 1 [Phase 2]
Phase 2 clinical trial update assessing dynorphin 1-13 for heroin addiction; the study conducted at the University of Minnesota has complete…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Efficacy of Extended Release Tramadol for Treating Prescription Opioid Withdrawal [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluated the efficacy of extended-release tramadol for treating prescription opioid withdrawal; results have bee…
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals [Phase 2]
A Phase 2 randomized trial compared gabapentin to placebo to facilitate buprenorphine detoxification in opioid-dependent individuals; result…